CN113373141A - Extraction method of free DNA - Google Patents
Extraction method of free DNA Download PDFInfo
- Publication number
- CN113373141A CN113373141A CN202110834748.1A CN202110834748A CN113373141A CN 113373141 A CN113373141 A CN 113373141A CN 202110834748 A CN202110834748 A CN 202110834748A CN 113373141 A CN113373141 A CN 113373141A
- Authority
- CN
- China
- Prior art keywords
- solution
- buffer solution
- sample
- washing
- extraction method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000605 extraction Methods 0.000 title claims abstract description 18
- 239000000243 solution Substances 0.000 claims abstract description 132
- 238000005406 washing Methods 0.000 claims abstract description 39
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000007853 buffer solution Substances 0.000 claims abstract description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000011324 bead Substances 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 24
- 238000002156 mixing Methods 0.000 claims abstract description 23
- 239000003480 eluent Substances 0.000 claims abstract description 22
- 229910020820 NaAc-HAc Inorganic materials 0.000 claims abstract description 21
- 239000006166 lysate Substances 0.000 claims abstract description 20
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000007984 Tris EDTA buffer Substances 0.000 claims abstract description 18
- 229940051841 polyoxyethylene ether Drugs 0.000 claims abstract description 18
- 229920000056 polyoxyethylene ether Polymers 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 claims abstract description 16
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims abstract description 16
- YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000005336 cracking Methods 0.000 claims abstract description 6
- 238000010828 elution Methods 0.000 claims abstract description 4
- 239000007788 liquid Substances 0.000 claims description 27
- 230000009089 cytolysis Effects 0.000 claims description 24
- 230000009471 action Effects 0.000 claims description 8
- 239000011259 mixed solution Substances 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 5
- 230000010355 oscillation Effects 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 4
- 102000004169 proteins and genes Human genes 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 36
- 230000000052 comparative effect Effects 0.000 description 13
- 239000000203 mixture Substances 0.000 description 12
- 238000007605 air drying Methods 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 6
- 102000053602 DNA Human genes 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 108010089610 Nuclear Proteins Proteins 0.000 description 1
- 102000007999 Nuclear Proteins Human genes 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000011112 process operation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/1013—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a method for extracting free DNA. The extraction method comprises the following steps: mixing a sample to be processed, a lysate and magnetic beads for cracking treatment to obtain a cracked sample, wherein the lysate comprises guanidine isothiocyanate, polyoxyethylene ether Brij58, NaAc-HAc buffer solution, isopropanol and water; washing the cracked sample by using a washing solution and an ethanol solution to obtain a washed sample, wherein the washing solution comprises guanidinium isothiocyanate and a Tris-HCl buffer solution; and mixing the washed sample with an eluent to carry out elution treatment to obtain free DNA, wherein the eluent comprises TE buffer. The method can extract free DNA through 3 steps of cracking, washing and eluting, is more efficient and convenient, and meanwhile, the lysate in the method can well destroy proteins and form a high-salt environment, so that the free DNA is better combined with magnetic beads.
Description
Technical Field
The invention belongs to the technical field of extraction and separation, and particularly relates to a method for extracting free DNA.
Background
Mandel et al first reported in 1948 the presence of free DNA (cfDNA) in plasma, which is an extracellular DNA, consisting mainly of single-or double-stranded DNA and a mixture of single-and double-stranded DNA. cfDNA exists in the peripheral blood of both healthy people and tumor patients, and the content of cfDNA in the peripheral blood of tumor patients is more than 10 times that of the cfDNA of healthy people. Clinical studies show that cfDNA can effectively reflect the overall tumor load, malignancy degree, metastatic capacity and real-time gene mutation information of patients, and has a certain correlation with the gene information of tumor tissues. The plasma cfDNA sequencing is used for detecting gene copy number change, methylation change, nucleotide mutation change, chromosome rearrangement change and the like related to tumors, and can be used for clinical diagnosis, medication guidance, detection of tumorigenesis and the like. Therefore, extracting high-quality cfDNA is a key for performing accurate analysis on the cfDNA, and the sensitivity and specificity of the extraction method are directly related to success or failure of subsequent experiments.
The nucleic acid extraction technology has undergone the processes from the 1 st generation chemical method to the 2 nd generation adsorption column method, and the 3 rd generation magnetic bead method developed in recent years, and the extraction technology and efficiency thereof are continuously improved and optimized. The current nucleic acid isolation and purification requires four important steps: disruption and lysis of tissue or cells, denaturation of nuclear protein complexes, inactivation of nucleases and removal of contaminants. How to provide a simple, rapid, and efficient method for separating cfDNA is a considerable problem to be studied.
Disclosure of Invention
The main object of the present invention is to provide a solution to the drawbacks of the prior art.
In order to achieve the purpose, the technical scheme adopted by the invention comprises the following steps:
the embodiment of the invention provides a method for extracting free DNA, which comprises the following steps:
(1) mixing a sample to be processed, a lysate and magnetic beads for cracking treatment to obtain a cracked sample, wherein the lysate comprises guanidine isothiocyanate, polyoxyethylene ether Brij58, NaAc-HAc buffer solution, isopropanol and water;
(2) washing the sample cracked in the step (1) by using a washing solution and an ethanol solution to obtain a washed sample, wherein the washing solution comprises guanidinium isothiocyanate and a Tris-HCl buffer solution;
(3) and (3) mixing the washed sample obtained in the step (2) with an eluent to carry out elution treatment, so as to obtain free DNA, wherein the eluent comprises TE buffer solution.
Further, the TE buffer has a pH of 10.
Compared with the prior art, the invention has the beneficial effects that: the method can extract free DNA through 3 steps of cracking, washing and eluting, is more efficient and convenient, and meanwhile, the lysate in the method can well destroy proteins and form a high-salt environment, so that the free DNA is better combined with magnetic beads.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only some embodiments described in the present invention, and for those skilled in the art, other drawings can be obtained according to the drawings without creative efforts.
FIG. 1 is a graph showing the results of molecular weight measurement of free DNA prepared in example 1 of the present invention.
Detailed Description
In view of the defects of the prior art, the inventor of the present invention has long studied and largely practiced to propose the technical solution of the present invention, which will be clearly and completely described below, and it is obvious that the described embodiments are a part of the embodiments of the present invention, but not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
One aspect of the embodiments of the present invention provides a method for extracting free DNA, which includes:
(1) mixing a sample to be processed, a lysate and magnetic beads for cracking treatment to obtain a cracked sample, wherein the lysate comprises guanidine isothiocyanate, polyoxyethylene ether Brij58, NaAc-HAc buffer solution, isopropanol and water;
(2) washing the sample cracked in the step (1) by using a washing solution and an ethanol solution to obtain a washed sample, wherein the washing solution comprises guanidinium isothiocyanate and a Tris-HCl buffer solution;
(3) and (3) mixing the washed sample obtained in the step (2) with an eluent to carry out elution treatment, so as to obtain free DNA, wherein the eluent comprises TE buffer solution.
In some specific embodiments, the volume ratio of the sample, the lysis solution and the magnetic beads is 100-200: 150-250: 0.5-3.
Furthermore, the concentration of the magnetic beads in the solution containing the magnetic beads is 10-100 mg/mL.
Further, the extraction method further comprises the following steps: and (2) centrifuging the cracked sample obtained in the step (1) for 1-2 min at the rotating speed of 1000-3000 rpm, and then separating under the action of a magnetic field.
In some more specific embodiments, the method of preparing the lysate comprises: guanidine isothiocyanate, polyoxyethylene ether Brij58 and NaAc-HAc buffer solution were mixed, and then water and isopropanol were added to obtain the lysate.
Further, the concentration of the NaAc-HAc buffer solution is 50-200 mmol/L.
Further, the pH value of the NaAc-HAc buffer solution is 4.0-6.0.
Furthermore, the volume content of isopropanol in the lysate is 10-50%.
Further, the volume ratio of the NaAc-HAc buffer solution to the isopropanol to the water is 1-10: 1-5.
In some more specific embodiments, the concentration of guanidinium isothiocyanate in the lysis solution is 5.0-6.0 mol/L.
Furthermore, the concentration of polyoxyethylene ether Brij58 in the lysis solution is 0.1-1.0 mmol/L.
In some more specific embodiments, step (2) specifically includes:
washing the cracked sample obtained in the step (1) by using a washing solution, and then separating under the action of a magnetic field;
and washing the mixed solution obtained by the separation treatment by using an ethanol solution, and then performing the separation treatment under the action of a magnetic field to obtain the washed sample.
In some more specific embodiments, the concentration of guanidinium isothiocyanate in the wash solution is 5.0-6.0 mol/L.
Furthermore, the concentration of the Tris-HCl buffer solution is 0.1-1 mol/L.
Further, the pH value of the Tris-HCl buffer solution is 4.0-8.0.
Further, the volume content of ethanol in the ethanol solution is 50-80%.
In some more specific embodiments, step (3) specifically includes: and (3) mixing the washed sample obtained in the step (2) with an eluent, oscillating, centrifuging, and separating under the action of a magnetic field to obtain the free DNA.
Further, the oscillation treatment time is 5-10 min.
In some more specific embodiments, the TE buffer has a pH of 10.
Further, the concentration of the TE buffer solution is 40-80 mmol/L.
Further, the sample includes plasma or serum, and is not limited thereto.
In some more specific embodiments, the method for extracting free DNA specifically comprises:
(1) taking a sample to be detected to a centrifuge tube, adding lysis solution and magnetic beads, wherein the volume ratio of the sample to be detected to the lysis solution to the magnetic beads is 100-200: 150-250: 0.5-3, uniformly mixing, and avoiding bubbles to generate as much as possible to obtain a mixed solution A;
(2) centrifuging the mixed solution A for 1-2 min at the rotating speed of 1000-3000 rpm, standing on a magnetic frame for 5-10 min until the solution is clear, and sucking the supernatant;
(3) taking the sample treated in the step (2) down from the magnetic frame, adding 1-10 mL of washing liquid, and mixing uniformly to avoid bubbles as much as possible to obtain a mixed liquid B;
(4) placing the mixed solution B on a magnetic frame, standing until the solution is clear, and sucking the supernatant;
(5) taking the sample treated in the step (4) down from the magnetic frame, adding 1-10 mL of 50% -80% ethanol, and mixing uniformly to obtain a mixture C;
(6) placing the mixed solution C on a magnetic frame, standing until the solution is clear, sucking the supernatant, opening a centrifugal tube cover, and air-drying the magnetic beads;
(7) taking the sample treated in the step (6) down from the magnetic frame, adding 10-50 mu L of eluent, and uniformly mixing to obtain a mixture D;
(8) and fully shaking the mixture D for 5-10 min, centrifuging, placing on a magnetic frame, standing until the solution is clear, and transferring the supernatant into a new centrifugal tube to obtain free DNA.
Preferably, the method for preparing the lysate in step (1) comprises: adding 1-5 mL of NaAc-HAc (pH value of 4.0-6.0) with concentration of 50-200 mmol/L into guanidinium isothiocyanate and polyoxyethylene ether Brij58, adding deionized water to 10mL, and adding 10-50% of isopropanol to obtain the product; wherein the concentration of the guanidinium isothiocyanate is 5.0-6.0 mol/L, and the concentration of the polyoxyethylene ether Brij58 is 0.1-1 mmol/L.
Preferably, the preparation method of the washing solution in the step (3) comprises the following steps: dissolving 5.0-6.0 mol/L guanidinium isothiocyanate in 0.1-1.0 mol/L LTris-HCl (pH value is 5.0-8.0) to obtain the guanidine isothiocyanate.
Preferably, the method for preparing the eluent in the step (7) comprises the following steps: 40-80 mmol/L TE buffer (pH 10).
The technical solution of the present invention is further described in detail with reference to several preferred embodiments, which are implemented on the premise of the technical solution of the present invention, and detailed embodiments and specific operation procedures are given, but the scope of the present invention is not limited to the following embodiments.
The experimental materials used in the examples used below were all available from conventional biochemical reagents companies, unless otherwise specified.
Example 1
(1) Putting 2mL of plasma into an 10/15mL centrifuge tube, adding 2.5mL of lysis solution (wherein the lysis solution comprises 5.0mol/L guanidine isothiocyanate, 0.5mmol/L polyoxyethylene ether Brij58, 100mmol/LpH NaAc-HAc buffer solution with the value of 5.0, 4mL of isopropanol and water) and 30 mu L of magnetic beads which are uniformly mixed and have the concentration of 40mg/mL, and uniformly mixing for 10min at room temperature to avoid the generation of bubbles as much as possible; then centrifuging at 1000rpm for 1-2 min; then, the solution is placed on a magnetic frame for 5min or until the solution is clarified, and the clarified solution is sucked off.
(2) Taking down the centrifugal tube from the magnetic frame, adding 1mL of washing solution (wherein the washing solution comprises 5.0mol/L guanidinium isothiocyanate and 0.1mol/L Tris-HCl buffer solution with the pH value of 6.0), and absorbing for 10 times by using a pipette gun to uniformly mix, so as to avoid the generation of bubbles as much as possible; then transferring to a new 1.5mL centrifuge tube, standing for 2min on a magnetic frame or until the solution is clear, and sucking clear liquid; and repeating the steps once.
(3) Taking the centrifugal tube off the magnetic frame, adding 1mL of 80% ethanol, shaking for 30s, centrifuging, placing the centrifugal tube on the magnetic frame for 2min or until the solution is clarified, removing the clarified solution by suction, and repeating the steps once; and opening the centrifugal tube cover, and air-drying the magnetic beads for 2-5 min.
(4) And (3) taking the centrifuge tube off the magnetic frame, adding 15 mu L of eluent (TE buffer solution with the value of 50mmol/LpH of 10.0), shaking for 5min, then simply centrifuging, placing the centrifuge tube on the magnetic frame for 2min or until the liquid is clear, and then sucking the clear liquid to a new centrifuge tube with the volume of 1.5mL to obtain free DNA.
The results of the measurement of the molecular weight of the free DNA in this example are shown in FIG. 1, and the results of the measurement of the concentration of the free DNA in this example are shown in Table 1.
Example 2
(1) Putting 2mL of plasma into an 10/15mL centrifuge tube, adding 2.5mL of lysis solution (wherein the lysis solution comprises 5.5mol/L guanidine isothiocyanate, 1.0mmol/L polyoxyethylene ether Brij58, 200mmol/L NaAc-HAc buffer solution with the pH value of 4.0, 4mL of isopropanol and water) and 30 mu L of magnetic beads which are uniformly mixed and have the concentration of 100mg/mL, and uniformly mixing for 10min at room temperature to avoid the generation of bubbles as much as possible; then centrifuging at 1000rpm for 1-2 min; then, the solution is placed on a magnetic frame for 5min or until the solution is clarified, and the clarified solution is sucked off.
(2) Taking down the centrifugal tube from the magnetic frame, adding 1mL of washing solution (wherein the washing solution comprises 6.0mol/L guanidinium isothiocyanate and 1.0mol/LpH value of Tris-HCl buffer solution of 8.0), and sucking back and forth for 10 times by using a pipette gun to uniformly mix, so as to avoid the generation of bubbles as much as possible; then transferring to a new 1.5mL centrifuge tube, standing for 2min on a magnetic frame or until the solution is clear, and sucking clear liquid; and repeating the steps once.
(3) Taking the centrifugal tube off the magnetic frame, adding 1mL of 60% ethanol, shaking for 30s, centrifuging, placing the centrifugal tube on the magnetic frame for 2min or until the solution is clarified, removing the clarified solution by suction, and repeating the steps once; and opening the centrifugal tube cover, and air-drying the magnetic beads for 2-5 min.
(4) Taking the centrifuge tube off the magnetic frame, adding 15 μ L of eluent (80mmol/L TE buffer solution with pH value of 10.0), shaking for 5min, centrifuging simply, placing the centrifuge tube on the magnetic frame for 2min or until the liquid is clear, and then sucking clear liquid into a new centrifuge tube of 1.5mL to obtain free DNA. The results of measuring the free DNA concentration in this example are shown in Table 1.
Example 3
(1) Putting 2mL of plasma into an 10/15mL centrifuge tube, adding 2.5mL of lysis solution (wherein the lysis solution comprises 5.5mol/L guanidine isothiocyanate, 0.1mmol/L polyoxyethylene ether Brij58, 100mmol/L NaAc-HAc buffer solution with the pH value of 5.0, 4mL of isopropanol and water) and 30 mu L of magnetic beads which are uniformly mixed and have the concentration of 40mg/mL, and uniformly mixing for 10min at room temperature to avoid the generation of bubbles as much as possible; then centrifuging at 1000rpm for 1-2 min; then, the solution is placed on a magnetic frame for 5min or until the solution is clarified, and the clarified solution is sucked off.
(2) Taking down the centrifugal tube from the magnetic frame, adding 1mL of washing solution (wherein the washing solution comprises 5.5mol/L guanidine isothiocyanate and 1.0mol/LpH value of 6.0 Tris-HCl buffer solution), and absorbing for 10 times by using a pipette gun to uniformly mix, so as to avoid the generation of bubbles as much as possible; then transferring to a new 1.5mL centrifuge tube, standing for 2min on a magnetic frame or until the solution is clear, and sucking clear liquid; and repeating the steps once.
(3) Taking the centrifugal tube off the magnetic frame, adding 1mL of 80% ethanol, shaking for 30s, centrifuging, placing the centrifugal tube on the magnetic frame for 2min or until the solution is clarified, removing the clarified solution by suction, and repeating the steps once; and opening the centrifugal tube cover, and air-drying the magnetic beads for 2-5 min.
(4) And (3) taking the centrifuge tube off the magnetic frame, adding 15 mu L of eluent (TE buffer solution with the value of 50mmol/LpH of 10.0), shaking for 5min, then simply centrifuging, placing the centrifuge tube on the magnetic frame for 2min or until the liquid is clear, and then sucking the clear liquid to a new centrifuge tube with the volume of 1.5mL to obtain free DNA. The results of measuring the free DNA concentration in this example are shown in Table 1.
Example 4
(1) Putting 2mL of plasma into an 10/15mL centrifuge tube, adding 2.5mL of lysis solution (wherein the lysis solution comprises 6.0mol/L guanidine isothiocyanate, 1.0mmol/L polyoxyethylene ether Brij58, 100mmol/L NaAc-HAc buffer solution with the pH value of 6.0, 4mL of isopropanol and water) and 30 mu L of magnetic beads which are uniformly mixed and have the concentration of 40mg/mL, and uniformly mixing for 10min at room temperature to avoid the generation of bubbles as much as possible; then centrifuging at 1000rpm for 1-2 min; then, the solution is placed on a magnetic frame for 5min or until the solution is clarified, and the clarified solution is sucked off.
(2) Taking down the centrifugal tube from the magnetic frame, adding 1mL of washing solution (wherein the washing solution comprises 6.0mol/L guanidinium isothiocyanate and 0.1mol/L Tris-HCl buffer solution with the pH value of 6.0), and absorbing for 10 times by using a pipette gun to uniformly mix, so as to avoid the generation of bubbles as much as possible; then transferring to a new 1.5mL centrifuge tube, standing for 2min on a magnetic frame or until the solution is clear, and sucking clear liquid; and repeating the steps once.
(3) Taking the centrifugal tube off the magnetic frame, adding 1mL of 80% ethanol, shaking for 30s, centrifuging, placing the centrifugal tube on the magnetic frame for 2min or until the solution is clarified, removing the clarified solution by suction, and repeating the steps once; and opening the centrifugal tube cover, and air-drying the magnetic beads for 2-5 min.
(4) Taking the centrifuge tube off the magnetic frame, adding 15 μ L of eluent (80mmol/L TE buffer solution with pH value of 10.0), shaking for 5min, centrifuging simply, placing the centrifuge tube on the magnetic frame for 2min or until the liquid is clear, and then sucking clear liquid into a new centrifuge tube of 1.5mL to obtain free DNA. The results of measuring the free DNA concentration in this example are shown in Table 1.
Comparative example 1
The method is the same as example 1, except that: the eluent used has a pH of 9;
(1) putting 2mL of plasma into an 10/15mL centrifuge tube, adding 2.5mL of lysis solution (wherein the lysis solution comprises 5.0mol/L guanidine isothiocyanate, 0.5mmol/L polyoxyethylene ether Brij58, 100mmol/L NaAc-HAc buffer solution with the pH value of 5.0, 4mL of isopropanol and water) and 30 mu L of magnetic beads which are uniformly mixed and have the concentration of 40mg/mL, and uniformly mixing for 10min at room temperature to avoid the generation of bubbles as much as possible; then centrifuging at 1000rpm for 1-2 min; then, the solution is placed on a magnetic frame for 5min or until the solution is clarified, and the clarified solution is sucked off.
(2) Taking down the centrifugal tube from the magnetic frame, adding 1mL of washing solution (wherein the washing solution comprises 5.0mol/L guanidinium isothiocyanate and 0.1mol/L Tris-HCl buffer solution with the pH value of 6.0), and absorbing for 10 times by using a pipette gun to uniformly mix, so as to avoid the generation of bubbles as much as possible; then transferring to a new 1.5mL centrifuge tube, standing for 2min on a magnetic frame or until the solution is clear, and sucking clear liquid; and repeating the steps once.
(3) Taking the centrifugal tube off the magnetic frame, adding 1mL of 80% ethanol, shaking for 30s, centrifuging, placing the centrifugal tube on the magnetic frame for 2min or until the solution is clarified, removing the clarified solution by suction, and repeating the steps once; and opening the centrifugal tube cover, and air-drying the magnetic beads for 2-5 min.
(4) And (3) taking the centrifuge tube off the magnetic frame, adding 15 mu L of eluent (TE buffer solution with the value of 50mmol/LpH of 9.0), shaking for 5min, then simply centrifuging, placing the centrifuge tube on the magnetic frame for 2min or until the liquid is clear, and then sucking the clear liquid to a new centrifuge tube with the volume of 1.5mL to obtain free DNA. The results of measuring the concentration of free DNA in this comparative example are shown in Table 1.
Comparative example 2
The method is the same as example 1, except that: the eluent used has a pH of 11;
(1) putting 2mL of plasma into an 10/15mL centrifuge tube, adding 2.5mL of lysis solution (wherein the lysis solution comprises 5.0mol/L guanidine isothiocyanate, 0.5mmol/L polyoxyethylene ether Brij58, 100mmol/L NaAc-HAc buffer solution with the pH value of 5.0, 4mL of isopropanol and water) and 30 mu L of magnetic beads which are uniformly mixed and have the concentration of 40mg/mL, and uniformly mixing for 10min at room temperature to avoid the generation of bubbles as much as possible; then centrifuging at 1000rpm for 1-2 min; then, the solution is placed on a magnetic frame for 5min or until the solution is clarified, and the clarified solution is sucked off.
(2) Taking down the centrifugal tube from the magnetic frame, adding 1mL of washing solution (wherein the washing solution comprises 5.0mol/L guanidinium isothiocyanate and 0.1mol/L Tris-HCl buffer solution with the pH value of 6.0), and absorbing for 10 times by using a pipette gun to uniformly mix, so as to avoid the generation of bubbles as much as possible; then transferring to a new 1.5mL centrifuge tube, standing for 2min on a magnetic frame or until the solution is clear, and sucking clear liquid; and repeating the steps once.
(3) Taking the centrifugal tube off the magnetic frame, adding 1mL of 80% ethanol, shaking for 30s, centrifuging, placing the centrifugal tube on the magnetic frame for 2min or until the solution is clarified, removing the clarified solution by suction, and repeating the steps once; and opening the centrifugal tube cover, and air-drying the magnetic beads for 2-5 min.
(4) And (3) taking the centrifuge tube off the magnetic frame, adding 15 mu L of eluent (TE buffer solution with the value of 50mmol/LpH of 11.0), shaking for 5min, then simply centrifuging, placing the centrifuge tube on the magnetic frame for 2min or until the liquid is clear, and then sucking the clear liquid to a new centrifuge tube with the volume of 1.5mL to obtain free DNA. The results of measuring the concentration of free DNA in this comparative example are shown in Table 1.
Comparative example 3
The method is the same as example 1, except that: the lysate lacks polyoxyethylene ether Brij 5;
(1) putting 2mL of plasma into an 10/15mL centrifuge tube, adding 2.5mL of lysis solution (wherein the lysis solution comprises 5.0mol/L guanidine isothiocyanate, 100mmol/L NaAc-HAc buffer solution with the pH value of 5.0, 4mL of isopropanol and water) and 30 mu L of 40mg/mL magnetic beads which are uniformly mixed, and uniformly mixing for 10min at room temperature to avoid the generation of bubbles as much as possible; then centrifuging at 1000rpm for 1-2 min; then, the solution is placed on a magnetic frame for 5min or until the solution is clarified, and the clarified solution is sucked off.
(2) Taking down the centrifugal tube from the magnetic frame, adding 1mL of washing solution (wherein the washing solution comprises 5.0mol/L guanidinium isothiocyanate and 0.1mol/L Tris-HCl buffer solution with the pH value of 6.0), and absorbing for 10 times by using a pipette gun to uniformly mix, so as to avoid the generation of bubbles as much as possible; then transferring to a new 1.5mL centrifuge tube, standing for 2min on a magnetic frame or until the solution is clear, and sucking clear liquid; and repeating the steps once.
(3) Taking the centrifugal tube off the magnetic frame, adding 1mL of 80% ethanol, shaking for 30s, centrifuging, placing the centrifugal tube on the magnetic frame for 2min or until the solution is clarified, removing the clarified solution by suction, and repeating the steps once; and opening the centrifugal tube cover, and air-drying the magnetic beads for 2-5 min.
(4) And (3) taking the centrifuge tube off the magnetic frame, adding 15 mu L of eluent (TE buffer solution with the value of 50mmol/LpH of 10.0), shaking for 5min, then simply centrifuging, placing the centrifuge tube on the magnetic frame for 2min or until the liquid is clear, and then sucking the clear liquid to a new centrifuge tube with the volume of 1.5mL to obtain free DNA. The results of measuring the concentration of free DNA in this comparative example are shown in Table 1.
Comparative example 4
The method is the same as example 1, except that: the polyoxyethylene ether Brij5 in the lysate is replaced by SDS.
(1) Putting 2mL of plasma into an 10/15mL centrifuge tube, adding 2.5mL of lysis solution (wherein the lysis solution comprises 5.0mol/L guanidine isothiocyanate, 0.5mmol/L LSDS, 100mmol/LpH NaAc-HAc buffer solution with the value of 5.0, 4mL of isopropanol and water) and 30 μ L of 40mg/mL magnetic beads which are uniformly mixed, and uniformly mixing for 10min at room temperature to avoid the generation of bubbles as much as possible; then centrifuging at 1000rpm for 1-2 min; then, the solution is placed on a magnetic frame for 5min or until the solution is clarified, and the clarified solution is sucked off.
(2) Taking down the centrifugal tube from the magnetic frame, adding 1mL of washing solution (wherein the washing solution comprises 5.0mol/L guanidinium isothiocyanate and 0.1mol/L Tris-HCl buffer solution with the pH value of 6.0), and absorbing for 10 times by using a pipette gun to uniformly mix, so as to avoid the generation of bubbles as much as possible; then transferring to a new 1.5mL centrifuge tube, standing for 2min on a magnetic frame or until the solution is clear, and sucking clear liquid; and repeating the steps once.
(3) Taking the centrifugal tube off the magnetic frame, adding 1mL of 80% ethanol, shaking for 30s, centrifuging, placing the centrifugal tube on the magnetic frame for 2min or until the solution is clarified, removing the clarified solution by suction, and repeating the steps once; and opening the centrifugal tube cover, and air-drying the magnetic beads for 2-5 min.
(4) And (3) taking the centrifuge tube off the magnetic frame, adding 15 mu L of eluent (TE buffer solution with the value of 50mmol/LpH of 10.0), shaking for 5min, then simply centrifuging, placing the centrifuge tube on the magnetic frame for 2min or until the liquid is clear, and then sucking the clear liquid to a new centrifuge tube with the volume of 1.5mL to obtain free DNA. The results of measuring the concentration of free DNA in this comparative example are shown in Table 1.
TABLE 1 results of determination of free DNA concentration in examples 1 to 4 and comparative examples 1 to 4
Name (R) | Concentration (ng/. mu.L) |
Example 1 | 3.35 |
Example 2 | 3.05 |
Example 3 | 3.17 |
Example 4 | 3.29 |
Comparative example 1 | 2.16 |
Comparative example 2 | 1.99 |
Comparative example 3 | 1.11 |
Comparative example 4 | 1.02 |
In addition, the inventors of the present invention have also made experiments with other materials, process operations, and process conditions described in the present specification with reference to the above examples, and have obtained preferable results.
It should be understood that the technical solution of the present invention is not limited to the above-mentioned specific embodiments, and all technical modifications made according to the technical solution of the present invention fall within the protection scope of the present invention without departing from the spirit of the present invention and the protection scope of the claims.
Claims (10)
1. A method for extracting free DNA, comprising:
(1) mixing a sample to be processed, a lysate and magnetic beads for cracking treatment to obtain a cracked sample, wherein the lysate comprises guanidine isothiocyanate, polyoxyethylene ether Brij58, NaAc-HAc buffer solution, isopropanol and water;
(2) washing the sample cracked in the step (1) by using a washing solution and an ethanol solution to obtain a washed sample, wherein the washing solution comprises guanidinium isothiocyanate and a Tris-HCl buffer solution;
(3) and (3) mixing the washed sample obtained in the step (2) with an eluent to carry out elution treatment, so as to obtain free DNA, wherein the eluent comprises TE buffer solution.
2. The extraction method according to claim 1, characterized in that: the volume ratio of the sample to the lysis solution to the magnetic beads is 100-200: 150-250: 0.5-3:
and/or, the extraction method further comprises the following steps: and (2) centrifuging the cracked sample obtained in the step (1) for 1-2 min at the rotating speed of 1000-3000 rpm, and then separating under the action of a magnetic field.
3. The extraction method according to claim 1, wherein the preparation method of the lysate comprises: mixing guanidinium isothiocyanate, polyoxyethylene ether Brij58 and NaAc-HAc buffer solution, and then adding water and isopropanol to obtain lysate;
preferably, the concentration of the NaAc-HAc buffer solution is 50-200 mmol/L; preferably, the pH value of the NaAc-HAc buffer solution is 4.0-6.0; preferably, the volume content of isopropanol in the lysate is 10-50%; preferably, the volume ratio of the NaAc-HAc buffer solution to the isopropanol to the water is 1-10: 1-5.
4. The extraction method according to claim 1, characterized in that: the concentration of the guanidinium isothiocyanate in the lysate is 5.0-6.0 mol/L;
and/or the concentration of polyoxyethylene ether Brij58 in the lysis solution is 0.1-1.0 mmol/L.
5. The extraction method according to claim 1, wherein the step (2) specifically comprises:
washing the cracked sample obtained in the step (1) by using a washing solution, and then separating under the action of a magnetic field;
and washing the mixed solution obtained by the separation treatment by using an ethanol solution, and then performing the separation treatment under the action of a magnetic field to obtain the washed sample.
6. The extraction method according to claim 1, characterized in that: the concentration of the guanidinium isothiocyanate in the washing liquid is 5.0-6.0 mol/L;
and/or the concentration of the Tris-HCl buffer solution is 0.1-1 mol/L;
and/or the pH value of the Tris-HCl buffer solution is 4.0-8.0.
7. The extraction method according to claim 1, wherein the step (3) specifically comprises:
and (3) mixing the washed sample obtained in the step (2) with an eluent, oscillating, centrifuging, and separating under the action of a magnetic field to obtain the free DNA.
8. The extraction method according to claim 7, characterized in that: the time of the oscillation treatment is 5-10 min.
9. The extraction method according to claim 1, characterized in that: the pH value of the TE buffer solution is 10;
and/or the concentration of the TE buffer solution is 40-80 mmol/L.
10. The extraction method according to claim 1, characterized in that: the sample to be treated comprises plasma and/or serum.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110834748.1A CN113373141A (en) | 2021-07-23 | 2021-07-23 | Extraction method of free DNA |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110834748.1A CN113373141A (en) | 2021-07-23 | 2021-07-23 | Extraction method of free DNA |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113373141A true CN113373141A (en) | 2021-09-10 |
Family
ID=77582712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110834748.1A Pending CN113373141A (en) | 2021-07-23 | 2021-07-23 | Extraction method of free DNA |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113373141A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113755488A (en) * | 2021-09-30 | 2021-12-07 | 天津津科生物科技有限责任公司 | Method for rapidly extracting high-purity plasmid DNA |
CN118256489A (en) * | 2024-05-31 | 2024-06-28 | 天根生化科技(北京)有限公司 | Extraction kit of circulating nucleic acid and extraction method of circulating nucleic acid |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101050414A (en) * | 2007-05-11 | 2007-10-10 | 复旦大学 | Kit for extracting DNA for sampling in minute quantities without wound, and method for extracting DNA |
CN105349532A (en) * | 2015-12-15 | 2016-02-24 | 杭州千基生物科技有限公司 | Method and kit for extracting free nucleic acid by using paramagnetic particle method |
CN106834277A (en) * | 2017-02-11 | 2017-06-13 | 上海塔歌生物技术有限公司 | A kind of paramagnetic particle method separates the method and separating kit of dissociative DNA |
CN107663521A (en) * | 2016-07-28 | 2018-02-06 | 深圳华大基因股份有限公司 | Plasma free nucleic acid extraction kit and its application |
CN109371010A (en) * | 2018-11-26 | 2019-02-22 | 广东腾飞基因科技股份有限公司 | A kind of paramagnetic particle method plasma DNA extracts kit and extracting method |
CN109913447A (en) * | 2019-04-04 | 2019-06-21 | 深圳市南科征途有限公司 | Free DNA extraction enrichment kit and free DNA extraction method |
-
2021
- 2021-07-23 CN CN202110834748.1A patent/CN113373141A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101050414A (en) * | 2007-05-11 | 2007-10-10 | 复旦大学 | Kit for extracting DNA for sampling in minute quantities without wound, and method for extracting DNA |
CN105349532A (en) * | 2015-12-15 | 2016-02-24 | 杭州千基生物科技有限公司 | Method and kit for extracting free nucleic acid by using paramagnetic particle method |
CN107663521A (en) * | 2016-07-28 | 2018-02-06 | 深圳华大基因股份有限公司 | Plasma free nucleic acid extraction kit and its application |
CN106834277A (en) * | 2017-02-11 | 2017-06-13 | 上海塔歌生物技术有限公司 | A kind of paramagnetic particle method separates the method and separating kit of dissociative DNA |
CN109371010A (en) * | 2018-11-26 | 2019-02-22 | 广东腾飞基因科技股份有限公司 | A kind of paramagnetic particle method plasma DNA extracts kit and extracting method |
CN109913447A (en) * | 2019-04-04 | 2019-06-21 | 深圳市南科征途有限公司 | Free DNA extraction enrichment kit and free DNA extraction method |
Non-Patent Citations (2)
Title |
---|
杨麒巍等: "5种血浆游离DNA提取方法的比较", 《中国体视学与图像分析》 * |
王晖等: "两步磁珠法提取血浆游离DNA的评价及临床应用", 《山西医科大学学报》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113755488A (en) * | 2021-09-30 | 2021-12-07 | 天津津科生物科技有限责任公司 | Method for rapidly extracting high-purity plasmid DNA |
CN118256489A (en) * | 2024-05-31 | 2024-06-28 | 天根生化科技(北京)有限公司 | Extraction kit of circulating nucleic acid and extraction method of circulating nucleic acid |
CN118256489B (en) * | 2024-05-31 | 2024-08-27 | 天根生化科技(北京)有限公司 | Extraction kit of circulating nucleic acid and extraction method of circulating nucleic acid |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106893777B (en) | Multi-site methylation kit for detecting colorectal cancer related genes and application thereof | |
CN105349532A (en) | Method and kit for extracting free nucleic acid by using paramagnetic particle method | |
CN113373141A (en) | Extraction method of free DNA | |
CN108949747B (en) | Kit for extracting RNA and application method | |
CN109207592B (en) | Kit for colorectal cancer detection and application thereof | |
CN106011131A (en) | Method for separating free nuclei free nucleic acids from plasma | |
CN111057705B (en) | Kit for extracting free nucleic acid and use method | |
CN109762874B (en) | Nucleic acid sedimentation aid, pregnant woman plasma free DNA extraction kit and method | |
CN106967712A (en) | Faeces DNA rapid extraction kit | |
CN112899266A (en) | Cracking binding solution for nucleic acid extraction, kit and application thereof | |
CN116376896A (en) | Kit for extracting plasma free DNA, preparation method and extraction method | |
CN108531575A (en) | Detect primer, kit and the method for the full exon sequence mutation of TERC genes | |
CN102115739B (en) | Method, reagent and kit for separating nucleic acids | |
Pujol et al. | Determination of genotypes of hepatitis C virus in Venezuela by restriction fragment length polymorphism | |
CN112941067A (en) | Lysis binding solution for whole blood nucleic acid extraction and kit and application thereof | |
CN110951724A (en) | Method for rapidly extracting nucleic acid DNA and/or RNA by Trizol | |
CN109679945B (en) | Settling agent for improving extraction rate of free DNA in plasma sample | |
CN113621606B (en) | Kit and method for extracting plasma free DNA | |
CN109439655B (en) | Kit and method suitable for extracting ultra-trace nucleic acid | |
CN112195239B (en) | Esophageal squamous carcinoma metastatic tissue and serum exosome marker and application thereof | |
CN113717970A (en) | Fecal genome extraction kit and use method thereof | |
CN110904095B (en) | Method for improving small fragment nucleic acid purification yield | |
CN113789323A (en) | Urine genome extraction kit and use method | |
CN112391455A (en) | Kit for homologous recombination repair defect detection | |
US9487820B2 (en) | Methods of nucleic acid liquid-phase extraction and detection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210910 |
|
RJ01 | Rejection of invention patent application after publication |